Properties for alpha Synuclein Lysate
| Product Category | Lysates |
|---|---|
| Quantity | 0.1 mg |
| Synonyms | MGC110988, NACP, PARK1, PARK4, PD1 |
| Shipping to | Not USA/Canada |
| PDF datasheet | View Datasheet |
| Manufacturer | Novus Biologicals Inc. |
Datasheet Extract
| Add. information | This product is manufactured by and sold under license from OriGene Technologies and its use is limited solely for research purposes. Research Areas: Neuroscience |
|---|---|
| Application | Western Blot, This product is intended for use as a positive control in Western Blot., Western Blot |
| Background | Alpha-synuclein is a member of the synuclein family, which also includes beta- and gamma-synuclein. Synucleins are abundantly expressed in the brain and alpha- and beta-synuclein inhibit phospholipase D2 selectively. SNCA may serve to integrate presynaptic signaling and membrane trafficking. Defects in SNCA have been implicated in the pathogenesis of Parkinson disease. SNCA peptides are a major component of amyloid plaques in the brains of patients with Alzheimer's disease. Two alternatively spliced transcripts of SNCA have been identified. Additional splicing may be present but the full-length nature of these variants has not been determined. [provided by RefSeq]. Transcript Variant: This variant (NACP140) is the longer transcript and encodes the longer isoform (NACP140). Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications. |
| Concentration | 1 mg/ml |
| Storage | Store at -20C. Avoid freeze-thaw cycles. |
| Targets |





